Related Experiment Videos

Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells

M Müschen1, D Re, A Bräuninger

  • 1Institute for Genetics, Department of Immunology, University of Cologne, Köln, Germany. markus.mueschen@uni-koeln.de

Cancer Research
|November 4, 2000
PubMed

Insights

Somatic mutations in the CD95 gene may allow Hodgkin and Reed-Sternberg (H/RS) cells in classical Hodgkin's disease (cHD) to evade apoptosis. These CD95 gene mutations, along with IkappaB alpha gene mutations, contribute to cHD development.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Classical Hodgkin's disease (cHD) involves Hodgkin and Reed-Sternberg (H/RS) cells, believed to originate from germinal center B cells.
  • The mechanisms by which these precursor cells evade apoptosis, a critical process in germinal centers, remain largely unknown.

Purpose of the Study:

  • To investigate somatic mutations in the CD95 gene within H/RS cells from cHD patients.
  • To determine the role of CD95 gene mutations in the escape of H/RS cell precursors from apoptosis.

Main Methods:

  • Single H/RS cells were isolated from 10 cHD cases using micromanipulation.
  • The CD95 gene, including its 5' regions and the death domain-coding exon, was analyzed for somatic mutations.
  • The IkappaB alpha gene was also examined for mutations.

Main Results:

  • Clonal mutations within the CD95 gene were identified in H/RS cells from two cHD cases.
  • Mutations included alterations in the 5' regions and the death domain, with some H/RS cells exhibiting monoallelic stop-codon or replacement mutations.
  • These CD95 mutations are predicted to impair CD95 function, potentially hindering apoptosis.
  • All analyzed H/RS cells also carried inactivating mutations in the IkappaB alpha gene.

Conclusions:

  • Somatic mutations in the CD95 gene are present in a subset of cHD cases.
  • These CD95 mutations may contribute to the survival of H/RS cell precursors by enabling escape from CD95-mediated apoptosis.
  • Mutations in the IkappaB alpha gene appear to precede CD95 gene mutations in the oncogenic pathway of cHD.

Related Concept Videos